CD103+ Dendritic Cells and Regulatory T cells in Food Allergy
食物过敏中的 CD103 树突状细胞和调节性 T 细胞
基本信息
- 批准号:7539730
- 负责人:
- 金额:$ 22.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-18 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adam11 geneAdoptive TransferAffectAll-Trans-RetinolAllergensAllergicAllergic ReactionAllergy to peanutsAnatomyAnimal ModelAntibodiesAntigensCCL22 geneCCR9 geneCD4 Positive T LymphocytesCD8B1 geneCell Adhesion MoleculesCell CommunicationCell physiologyCellsColitisComplexCytokine ReceptorsDataDendritic CellsDevelopmentDiagnosisDiarrheaDiseaseDisease OutcomeDisease susceptibilityDoseEnvironmental Risk FactorEosinophiliaEpithelialExhibitsFoodFood HypersensitivityGastrointestinal tract structureGene Expression ProfileGeneticGoalsHandHelper-Inducer T-LymphocyteHomingHypersensitivityITGAM geneIgEImmunizationImmunotherapeutic agentIn VitroInbred BALB C MiceIndividualInflammationInflammatoryInflammatory disease of the intestineIntegrinsIntestinesLinkLungMHC Class I GenesMediatingMesenteryMicroarray AnalysisModelingMucous MembraneMusMutant Strains MiceNumbersOrganOvalbuminPlayPopulationPositioning AttributePreventionProcessProteinsPublic HealthRag1 MouseReagentRoleRouteSerumSkinSorting - Cell MovementStructure of aggregated lymphoid follicle of small intestineT-Cell ReceptorT-LymphocyteTh2 CellsTherapeutic AgentsTight JunctionsTransgenesTransgenic MiceVisceralVitamin AWeaningWild Type Mousecell typechemokinechlorambucil/dactinomycin/methotrexate protocoleosinophilfood allergenin vivolymph nodesmacrophage-derived chemokinemutantnovelresearch studyresponsesecretory protein
项目摘要
DESCRIPTION (provided by applicant): Food allergies affect 3-6% of the population and are difficult to diagnose and treat. Allergenic responses to food antigens are normally held in check by mucosal tolerance. A key player for maintaining this food tolerance is the regulatory T cells which in turn can be induced by a dendritic cell subset which expresses the adhesion molecule CD103. This dendritic cell type provides the link between food allergens and regulatory T cells and tolerance because they are located at the epithelial layer of the gastrointestinal tract and are equipped with tight junction proteins for their ready access to the intestinal lumen. However, CD103+ DC can also activate T helper 2 cells which participate in allergic responses and provide help for IgE synthesis and eosinophil development. Because this CD103+ dendritic cell type occupy such an important position in the decision of whether an immunological response to a food allergen is toleragenic or allergenic, more thorough understanding of the functions of this dendritic cell type in allergen responses in the intestines is warranted. Large amounts of preliminary data showing the phenotypic and functional differences between this and other dendritic cell subsets have been gathered and reagents and mutant mouse have been generated for the studies of CD103+ dendritic cells in food allergy. The long term goal of this project is to elucidate the function of CD103+ dendritic cells in mediating antigenic responses in the intestines and to develop therapeutic agents for food allergy treatment. An animal model for inducing intestinal allergic reactions to ovalbumin with eosinophilia, serum IgE levels, T helper 2 responses, intestinal inflammation, and diarrhea as indicators of allergy induction has been developed. A regulatory T cell deficient model as well as a mouse that provides large numbers of antigen-specific regulatory T cells have also been established. These mice will be used for studying the functions of integrin CD103 and CD103+ DC in food allergy and the efficacy of antigen-specific regulatory T cells in suppressing food allergies. The specific aims are: (1) to study the role of CD103 and CD103+ dendritic cells in mediating allergenic responses to ovalbumin using CD103 deficient mice and anti-CD103 antibodies. The role of CD103+ DC in allergic reactions will be confirmed by immunizing CD103 deficient recipients that are adoptive transferred with CD103+ wild-type dendritic cells; (2) to study the suppression of the responses of regulatory T cell deficient ovalbumin-specific T cell receptor transgenic mice by graded doses of ovalbumin-specific regulatory T cells. The ability of the antigen-specific regulatory T cell to cross-inhibit the responses of an unrelated antigen and the regulatory T cell stimulation by the synthesis of the chemokine CCL22/MDC by CD103+ dendritic cells will be studied. The studies will establish the importance of CD103+ dendritic cells in food allergy and may help in the development of anti-CD103, regulatory T cells, or CCL22/MDC as immunotherapeutic agents.
描述(由申请人提供):食物过敏会影响3-6%的人口,难以诊断和治疗。通常,对食物抗原的过敏性反应通常会通过粘膜耐受性检查。维持这种食物耐受性的关键参与者是调节性T细胞,进而由表达粘附分子CD103的树突状细胞子集诱导。这种树突状细胞类型提供了食物过敏原与调节性T细胞和耐受性之间的联系,因为它们位于胃肠道的上皮层,并配备了紧密的连接蛋白,以便它们可以使用肠腔。但是,CD103+ DC还可以激活参与过敏反应的T辅助2个细胞,并为IgE合成和嗜酸性粒细胞发育提供帮助。因为这种CD103+树突状细胞类型在决定中对食物过敏原的免疫反应是否具有耐兴奋性或过敏性,因此对这种树突状细胞类型在肠道中的过敏原反应中的功能更详尽地理解。已经收集了大量的初步数据,显示了该和其他树突状细胞亚群之间的表型和功能差异,并为食物过敏中的CD103+树突状细胞的研究生成了试剂和突变小鼠。该项目的长期目标是阐明CD103+树突状细胞在介导肠中介导抗原反应并开发用于食物过敏治疗的治疗剂的功能。一种用于诱导肠胃蛋白与嗜酸性粒细胞,血清IgE水平,T助手2反应,肠炎和腹泻的动物模型,已开发出作为过敏诱导的指标。还建立了一个提供大量抗原特异性调节T细胞的调节性T细胞缺陷模型和小鼠。这些小鼠将用于研究整联蛋白CD103和CD103+ DC在食物过敏中的功能,以及抗原特异性调节性T细胞在抑制食物过敏中的功效。具体目的是:(1)研究CD103和CD103+树突状细胞在使用CD103缺陷小鼠和抗CD103抗体中介导对卵蛋白的过敏性反应中的作用。 CD103+ DC在过敏反应中的作用将通过免疫CD103的缺陷受体来证实,这些受体被用CD103+野生型树突状细胞转移。 (2)研究调节性T细胞缺乏卵巢蛋白特异性T细胞受体转基因小鼠的抑制作用,分为椭圆蛋白特异性的调节性T细胞。将研究抗原特异性调节性T细胞通过CD103+树突状细胞合成通过趋化因子CCL22/MDC合成的无关抗原和调节性T细胞刺激的反应的能力。研究将确定CD103+树突状细胞在食物过敏中的重要性,并可能有助于抗CD103,调节性T细胞或CCL22/MDC作为免疫治疗剂的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sun-Sang Joseph Sung其他文献
Sun-Sang Joseph Sung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sun-Sang Joseph Sung', 18)}}的其他基金
NLRP3 Inflammasome Activation, T Follicular Helper Cells and Autoimmunity
NLRP3 炎症小体激活、滤泡辅助 T 细胞和自身免疫
- 批准号:
10686392 - 财政年份:2020
- 资助金额:
$ 22.73万 - 项目类别:
NLRP3 Inflammasome Activation, T Follicular Helper Cells and Autoimmunity
NLRP3 炎症小体激活、滤泡辅助 T 细胞和自身免疫
- 批准号:
10459502 - 财政年份:2020
- 资助金额:
$ 22.73万 - 项目类别:
Infections, Microbiome and HLA-DR in the Induction of Lupus Related Auto-antibodies
感染、微生物组和 HLA-DR 在狼疮相关自身抗体诱导中的作用
- 批准号:
10443777 - 财政年份:2018
- 资助金额:
$ 22.73万 - 项目类别:
CD103+ Dendritic Cells and Regulatory T cells in Food Allergy
食物过敏中的 CD103 树突状细胞和调节性 T 细胞
- 批准号:
7846695 - 财政年份:2009
- 资助金额:
$ 22.73万 - 项目类别:
CD103+ Dendritic Cells and Regulatory T cells in Food Allergy
食物过敏中的 CD103 树突状细胞和调节性 T 细胞
- 批准号:
7638423 - 财政年份:2008
- 资助金额:
$ 22.73万 - 项目类别:
Asthma Induction by Dendritic Cells and Th2 Cells
树突状细胞和 Th2 细胞诱导哮喘
- 批准号:
6841211 - 财政年份:2004
- 资助金额:
$ 22.73万 - 项目类别:
Asthma Induction by Dendritic Cells and Th2 Cells
树突状细胞和 Th2 细胞诱导哮喘
- 批准号:
6987170 - 财政年份:2004
- 资助金额:
$ 22.73万 - 项目类别:
Asthma Induction by Dendritic Cells and Th2 Cells
树突状细胞和 Th2 细胞诱导哮喘
- 批准号:
6724710 - 财政年份:2004
- 资助金额:
$ 22.73万 - 项目类别:
Asthma Induction by Dendritic Cells and Th2 Cells
树突状细胞和 Th2 细胞诱导哮喘
- 批准号:
7152919 - 财政年份:2004
- 资助金额:
$ 22.73万 - 项目类别:
相似海外基金
Regulation of prostate organogenesis by tissue-resident macrophages
组织驻留巨噬细胞对前列腺器官发生的调节
- 批准号:
10555589 - 财政年份:2023
- 资助金额:
$ 22.73万 - 项目类别:
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
$ 22.73万 - 项目类别:
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 22.73万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 22.73万 - 项目类别: